Osaic Holdings’s Dyne Therapeutics DYN Stock Holding History

Osaic Holdings’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.4K	Buy	1,290 +655	+103%	+$11.3K	﹤0.01%	5755
2025 Q4	$12.4K	Sell	635 -6	-0.9%	-$114	﹤0.01%	6200
2025 Q3	$8.16K	Buy	641 +621	+3,105%	+$7.08K	﹤0.01%	6489
2025 Q2	$190	Sell	20 -7	-26%	-$77	﹤0.01%	7508
2025 Q1	$282	Buy	27 +12	+80%	+$172	﹤0.01%	7113
2024 Q4	$353	Sell	15 -8,645	-100%	-$256K	﹤0.01%	7085
2024 Q3	$311K	Buy	8,660 +8,614	+18,726%	+$343K	﹤0.01%	3284
2024 Q2	$1.62K	Sell	46 -32,364	-100%	-$940K	﹤0.01%	6672
2024 Q1	$920K	Buy	+32,410	New	+$733K	﹤0.01%	2419

Other funds holding DYN

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Osaic Holdings's DYN Position: Q1 2026 in Review

Osaic Holdings increased its Dyne Therapeutics (DYN) stake by 103% in Q1 2026, buying an estimated $11.3K and bringing the position to 1,290 shares worth $23.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5755.

Osaic Holdings first reported a position in DYN in Q1 2024 and has held it in 9 quarters since. The position peaked at $920K in Q1 2024. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

Osaic Holdings held 1,290 shares of Dyne Therapeutics worth $23.4K as of Q1 2026.
Osaic Holdings bought 655 Dyne Therapeutics shares in Q1 2026, an estimated $11.3K.
Dyne Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5755 holding.
Osaic Holdings first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 9 quarters since.
Osaic Holdings's Dyne Therapeutics position peaked at $920K in Q1 2024.
227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.